Novel HDAC6 selective inhibitors with 4-aminopiperidine-1- carboxamide as the core structure enhanced growth inhibitory activity of bortezomib in MCF-7 cells-Reference-Cited by-同舟云学术

Novel HDAC6 selective inhibitors with 4-aminopiperidine-1- carboxamide as the core structure enhanced growth inhibitory activity of bortezomib in MCF-7 cells

Published:2019-02-28 Issue:1 Volume:13 Page:91-97
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Zhao Chenru¹²,Gao Jianjun¹,Zhang Li²,Su Li²,Luan Yepeng²

Affiliation:

1. Department of Pharmacology, School of Pharmacy, Qingdao University

2. Department of Medicinal Chemistry, School of Pharmacy, Qingdao University

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health (social science)

Link

https://www.jstage.jst.go.jp/article/bst/13/1/13_2019.01049/_pdf

Reference24 articles.

1. 1. Di Gennaro E, Bruzzese F, Caraglia M, Abruzzese A, Budillon A. Acetylation of proteins as novel target for antitumor therapy: Review article. Amino Acids. 2004; 26:435-441.

2. 2. Secrist JP, Zhou X, Richon VM. HDAC inhibitors for the treatment of cancer. Curr Opin Investig Drugs. 2003; 4:1422-1427.

3. 3. Zhang Y, Fang H, Jiao J, Xu W. The structure and function of histone deacetylases: The target for anti-cancer therapy. Curr Med Chem. 2008; 15:2840-2849.

4. 4. West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J Clin Invest. 2014; 124:30-39.

5. 5. Zhang L, Han Y, Jiang Q, Wang C, Chen X, Li X, Xu F, Jiang Y, Wang Q, Xu W. Trend of histone deacetylase inhibitors in cancer therapy: Isoform selectivity or multitargeted strategy. Med Res Rev. 2015; 35:63-84.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents;Bioorganic Chemistry;2024-09

2. Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design;Bioorganic Chemistry;2023-09

3. HDAC6: A unique HDAC family member as a cancer target;Cellular Oncology;2022-08-29

4. Dihydropyrazole-Carbohydrazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the HDAC6;Pharmaceuticals;2022-05-31

5. Dihydropyrazole-Carbohydazide Derivatives with Dual Activity as Antioxidant and Anti-Proliferative Drugs on Breast Cancer Targeting the Hdac6;SSRN Electronic Journal;2022